Drug pricing transparency is currently a hot government topic: On October 10, President Trump signed two bills designed to end the drug industry's "gag order" of pharmacists, which prevent them from discussing cheaper price options with consumers.… more »

A recent Forbes.com headline refers to U.S. prescription drug pricing practices as "Lessons in Obfuscation." Unlike most products that have clearly defined prices, prescription drugs start with a list price set by the manufacturer, which is then… more »

If you’re a client, you already know that 100% of all paid manufacturer rebates go back to our clients. But true Rx transparency also demands that consumers know what they're paying for their medications – and so we provide that, too. Simply by logging… more »

On June 19 and 20, MedBen Vice President of Compliance Caroline Fraker revisited Washington, D.C. with fellow members of the Society of Professional Benefit Administrators (SPBA) Board of Directors, to speak with government officials on matters of… more »

At a recent MedBen University event, MedBen Vice President of Sales & Marketing Brian Fargus warned attendees against drug rebate guarantees that promise a lot but deliver little… and end up costing the employer more. “Some of the larger health… more »

Newly appointed Health and Human Services Secretary Alex Azar says he wants to see greater transparency in drug pricing. In an address to the Federation of American Hospitals last month, Azar noted that “in both healthcare services and pharmaceuticals,… more »

Pharmacy benefit transparency has been given a national spotlight with Anthem’s well-publicized allegations that Express Scripts overcharged them for prescription drugs (creating, in Anthem's words, an “obscene profit windfall”). In the latest… more »